Strengthening bioterrorism prevention: Global biological materials management

Biosecurity and Bioterrorism

Volumn 5, Issue 2, 2007, Pages 107-116

  Salerno, Reynolds M ^a   Hickok, Lauren T ^b  

^a SANDIA NATIONAL LABORATORIES   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

BIOLOGICAL WARFARE; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; REVIEW; UNITED STATES;

BIOLOGICAL PRODUCTS; BIOTERRORISM; INTERNATIONAL COOPERATION; SECURITY MEASURES; UNITED STATES;

EID: 34547398052     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2006.0027     Document Type: Review

References (57)

1. Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, National Research Council. Biotechnology Research in an Age of Terrorism: Confronting the Dual Use Dilemma. Washington, DC: National Academy of Sciences; 2003.
2. Nixdorff K, Bender W. Biotechnology, ethics of research, and potential military spin-off. INESAP Bulletin 2002; 19. Available at: http://www.inesap.org/bulletin19/bul19art05.htm. Accessed April 18,2007.
3. Kwik G, Fitzgerald J, Inglesby TV, O'Toole T. Biosecurity: responsible stewardship of bioscience in an age of catastrophic terrorism. Biosecur Bioterror 2003;1(1):27-35.
4. Salerno RM, Gaudioso J, Frerichs RL, Estes D. A BW risk assessment: historical and technical perspectives. Nonproliferation Review 2004;11(3).
5. Office of Transnational Issues. The Darker Bioweapons Future. Washington, DC: Central Intelligence Agency; November 3, 2003. Available at: http://www.fas.org/irp/cia/product/bw1103.pdf. Accessed April 18, 2007.
6. Mapping the Global Future. Report of the National Intelligence Council's 2020 Project. Washington, DC: National Intelligence Council; 2004. Available at: http://www.dni.gov/nic/NIC_globaltrend2020.html. Accessed April 18, 2007.
7. Commission on the Intelligence Capabilities of the United States Regarding Weapons of Mass Destruction. Report to the President of the United States. Washington, DC: Commission on the Intelligence Capabilities of the United States; 2005. Available at: http://www.whitehouse.gov/wmd/. Accessed April 18, 2007.
8. The White House. Biodefense for the 21st Century. Washington, DC: White House; 2004. Available at: http://www. whitehouse.gov/homeland/20040430. html. Accessed April 18, 2007.
9. UN Security Council Resolution 1540 (2004). New York: United Nations; April 28, 2004. Available at: http://www. state.gov/documents/organization/ 32097.pdf. Accessed April 18, 2007.
10. Appeal on Biotechnology, Weapons and Humanity. Geneva: International Committee of the Red Cross; 2002. Available at: http://www.icrc.org/Web/eng/siteeng0.nsf/htmlall/5EAMT T. Accessed April 18, 2007.
11. Preventing Bioterrorism: The 1st Interpol Global Conference to strengthen law enforcement preparedness and develop effective police training. Paris: Interpol; 2005. See: http://www.interpol.int/Public/BioTerrorism/Conferences/ 1stGlob alConference.asp. Accessed April 18, 2007.
12. International Futures Programme (IFP). Program on Biosecurity. Paris: Organization for Economic Cooperation and Development; 2004. Available at: http://www.biosecuritycodes. org/about.htm. Accessed April 18, 2007.
13. National Science Advisory Board for Biosecurity. 2005. See: http://www.biosecurityboard.gov/index.asp. Accessed April 18, 2007.
14. Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, National Research Council. Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: National Academy Press; 2006.
15. Somerville MA, Atlas RM. Ethics: a weapon to counter bioterrorism. Science 25 March 2005;307:1881-1882.
16. Steinbruner J, Harris ED. Controlling dangerous pathogens. Issues Sci Technol 9 April 2003. Available at: http://www. issues.org/19.3/steinbruner. htm. Accessed April 18, 2007.
17. Steinbruner J, Harris ED, Gallagher N, Okutani S. Controlling Dangerous Pathogens: A Prototype Protective Oversight System. College Park, Md: Center for International and Security Studies at Maryland; 2005. Available at: http://www.cissm. umd.edu/papers/files/pathogens_project_monograph.pdf. Accessed April 18, 2007.
18. Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 2001;75(3):1205-1210.
19. Cello J, Paul AV, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 2002;297(5583):1016-1018.
20. Smith HO, Hutchison CA 3rd, Pfannkoch C, Venter JC. Generating a synthetic genome by whole genome assembly: phi X174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci U S A 2003;100(26):15440-15445.
21. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005;310(5745):77-80.
22. Atlas RM, Reppy J. Globalizing biosecurity. Biosecur Bioterror 2005;3(1):51-60.
23. Barletta M, Sands A, Tucker JB. Keeping track of anthrax: the case for a pathogen security convention. Bull At Sci 2002;58(3).
24. Kellman B. Draft Convention on the Prohibition and Prevention of Biological Terrorism 2002. Prepared for the Workshop on Biological Terrorism - An International Criminal Law Approach; April 29, 2002. Chicago: International Human Rights Law Institute, DePaul University; 2002. Available at: http://www.law.edpaul.edu/institutes_centers/ihrli/_downloads/draft_convention. pdf. Accessed April 18, 2007.
25. Public consultation on the proposed Biological Agents and Toxins Act. Presented at Regional Emerging Disease Intervention (REDI) Centre Meeting on International Laboratory Biosafety and Biosecurity; April 7-8, 2005; Ministry of Health, Singapore.
26. Donahue LK. Censoring science won't make us any safer. Washington Post June 26, 2005.
27. Scheuer M. Through Our Enemies' Eyes: Osama bin Laden, Radical Islam, and the Future of America. Dulles, Va: Brassey's; 2002.
28. Petro JB, Relman DA. Understanding threats to scientific openness. Science December 12, 2003;302:1898.
29. Anisimov AP, Lindler LE, Pier GB. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev 2004;17(2):434-464.
30. World Health Organization. Human plague in 2002 and 2003. Wkly Epidemiol Rec August 13, 2004;79(33):301-308.
31. Available at: http://www.who.int/wer/2004/en/wer7933.pdf. Accessed April 19, 2007.
32. Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol Feb 2001;75(3):1205-1210.
33. Vogel KM. Pathogen proliferation: threats from the former Soviet bioweapons complex. Politics Life Sciences 2000;19(1): 3-16.
34. Cook MS, Woolf AF. Preventing Proliferation of Biological Weapons: U.S. Assistance to the Former Soviet States. Washington, DC: Congressional Research Service; April 10, 2002. Available at: http://fpc.state.gov/documents/ organization/9658.pdf. Accessed April 19, 2007.
35. Luongo KN, Averre D, Delia Ratta R, Martellini M. Building a forward line of defense: securing former Soviet biological weapons. Arms Control Today 2004;34(6).
36. Petro JB, Carus WS. Biological threat characterization research: a critical component of national biodefense. Biosecur Bioterror 2005;3(4):295-308.
37. Code of Federal Regulations, Title 42, Parts 72 and 73. Code of Federal Regulations, Title 7 Part 331. Code of Federal Regulations, Title 9, Part 121.
38. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8(2):225-230.
39. Casadevall A, Pirofski LA. The weapon potential of a microbe. Trends Microbiol 2004;12(6):259-263.
40. Gaudioso J, Salerno RM. Science and government. Biosecurity and research: minimizing adverse impacts. Science April 30, 2004;304(5671):687.
41. Gaudioso J, Salerno RM, Barnett N. Developing a risk assessment and management approach to laboratory biosecurity. Applied Biosafety 2006;11(1):24-31.
42. World Health Organization. Laboratory Biosafety Manual. 3rd ed. Geneva: World Health Organization; 2004. Available at: http://www.paho.org/ English/AD/THS/EV/LAB-Biosafety_ OMS.pdf. Accessed April 19, 2007.
43. World Health Organization. Biorisk Management: Laboratory Biosecurity Guidance. Geneva: World Health Organization; 2006. Available at: http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_EPR_2006_6/en/ index. html. Accessed April 19, 2007.
44. Tucker JB. Biosecurity: Limiting Terrorist Access to Deadly Pathogens. Peaceworks No. 52. Washington, DC: United States Institute of Peace; 2003. Available at: http://www. usip.org/pubs/peaceworks/pwks52.pdf. Accessed April 19, 2007.
45. Salerno RM, Estes D. Biosecurity: protecting high consequence pathogens and toxins against theft and diversion. In: Pilch R, Zilinskas R, eds. Encyclopedia of Bioterrorism Defense. Hoboken, NJ: Wiley; 2005.
46. Rao V, Eilers A, Mancini C. Select agents diagnostic test reporting requirements - exemptions and implications to biosecurity. Applied Biosafety 2006;11(4):215-221.
47. The Physical Protection of Nuclear Material and Nuclear Facilities. INFCIRC/225/Rev.4. Vienna: International Atomic Energy Agency; 1999. Available at: http://www.iaea.org/Publications/Documents/Infcircs/1999/ infcirc225r4c//rev4_content.html. Accessed April 19, 2007.
48. Code of Conduct on the Safety and Security of Radioactive Sources. Vienna: International Atomic Energy Agency; 2004. Available at: http://www-ns.iaea.org/tech-areas/radiationsafety/code-of-conduct.htm. Accessed April 19, 2007.
49. Review of the Implementation of the IAEA Nuclear Security Plan of Activities: 2002-2005. Vienna: International Atomic Energy Agency, 2006.
50. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. Biological warfare: a historical perspective. In: Lederberg J, ed. Biological Weapons: Limiting the Threat. Cambridge, Mass: MIT Press; 1999: Chap. 3.
51. Kuiken T, Leighton FA, Fouchier RAM, et al. Pathogen surveillance in animals. Science September 9, 2005;309:1680-1681.
52. Jebara KB. Surveillance, detection and response: managing emerging diseases at national and international levels. Rev Sci Tech 2004;23(2):709-715.
53. Butler D. Disease surveillance needs a revolution. Nature March 2, 2006;440:6-7.
54. Global Livestock Production and Health Atlas. Rome, Italy: Food and Agriculture Organization; 2004. Available at: http://www.fao.org/ag/aga/ glipha/index.jsp. Accessed April 19, 2007.
55. Risk assessment on foot and mouth disease. EFSA Journal 2006;313:1-34. Available at: http://www.efsa.europa.eu/etc/medialib/efsa/ science/ahaw/ahaw_opinions/1357.Par.0001. File.dat/ahaw_op_ej313_fmd_en1.pdf. Accessed April 19, 2007.
56. Wheelis M, Casagrande R, Madden LV. Biological attack on agriculture: low-tech, high-impact bioterrorism. BioScience 2002;52(7):569-576.
57. Cupp OS, Walker DE II, Hillison J. Agroterrorism in the U.S.: key security challenges for the 21st century. Biosecur Bioterror 2004;2(2):97-105.